Association of Type 2 Diabetes with Cyclooxygenase-Mediated Inflammation and Oxidative Stress in an Elderly Population

Circulation

Volumn 109, Issue 14, 2004, Pages 1729-1734

  Helmersson, Johanna ^a   Vessby, Bengt ^a   Larsson, Anders ^a   Basu, Samar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Diabetes mellitus; Free radicals; Inflammation; Prostaglandins

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN F2 ALPHA; 8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; ARACHIDONIC ACID; C REACTIVE PROTEIN; INSULIN; PROSTAGLANDIN SYNTHASE; SERUM AMYLOID A;

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

AGED; ALPHA-TOCOPHEROL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DINOPROST; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INSULIN; LIPIDS; MALE; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SERUM AMYLOID A PROTEIN; SWEDEN;

EID: 4344655589     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000124718.99562.91     Document Type: Article

References (33)

1. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
2. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199-204.
3. Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J. 2002;23:831-834.
4. Vane JR. Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res. 1976;2:791-801.
5. Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids. 1998;58: 347-352.
6. Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett. 1998;438:159-160.
7. Basu S, Nozari A, Liu XL, et al. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett. 2000;470:1-6.
8. McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism. 1989;38:1042-1046.
9. Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000;23:1835-1839.
10. Kuyvenhoven JP, Meinders AE. Oxidative stress and diabetes mellitus: pathogenesis of long term complications. Eur J Intern Med. 1999; 10:9-19.
11. Morrow JD, Hill KE, Burk RF, et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990;87: 9383-9387.
12. Gopaul NK, Änggård EE, Mallet AI, et al. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 1995;368:225-229.
13. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99:224-229.
14. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
15. Reilly MP, Pratico D, Delanty N, et al. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation. 1998;98:2822-2828.
16. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia. 1997;40:647-653.
17. Singh RB, Ghosh S, Niaz MA, et al. Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol. 1995;76:1233-1238.
18. Gopaul NK, Manraj MD, Hebe A, et al. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia. 2001;44:706-712.
19. Byberg L, Siegbahn A, Berglund L, et al. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. Arterioscler Thromb Vasc Biol. 1998;18:258-264.
20. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complication: Report of a WHO Consultation. Geneva: World Health Organization; 1999. Publication WHO/NCD/NCS/99.2.
21. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids. 1998;58:319-325.
22. Öhrvall M, Tengblad S, Vessby B, Lower tocopherol serum levels in subjects with abdominal adiposity. J Intern Med. 1993;234:53-60.
23. Bergström S. Prostaglandins: members of a new hormonal system: these physiologically very potent compounds of ubiquitous occurrence are formed from essential fatty acids. Science. 1967;157:382-391.
24. Davi G, Catalano I, Averna M, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990;322: 1769-1774.
25. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes. 2001;50:2384-2389.
26. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286: 327-334.
27. Devaraj S, Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med. 2000;29:790-792.
28. Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997;40: 1286-1292.
29. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131-2135.
30. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
31. Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 2000;28:505-513.
32. Meagher EA, Barry OP, Lawson JA, et al. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA. 2001;285:1178-1182.
33. Calder PC, Grimble RF. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr. 2002;56:S14-S19.